Skip to content

FP7H2020HORIZON

Universitatsklinikum Erlangen

Country
DEGermany
Defence projects
0
Projects, all programmes
66
As coordinator
16
EU contribution (CORDIS)
EUR 39,446,443
Active
2008 to 2025

Projects

66 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
OrbEEtORganizational Behaviour improvement for Energy Efficient adminisTrative public officesH20202015ParticipantEUR 153,313
REDOXITReactive oxygen species (ROS) as Elixirs against chronic Disease: OXidative regulatory mechanisms In T cells and neutrophils.H20202015ParticipantEUR 58,500
CLOSEDClonidine for Sedation of Paediatric Patients in the Intensive Care UnitFP72013CoordinatorEUR 1,803,611
EPIMIRNAMicroRNAs in the Pathogenesis, Treatment and Prevention of EpilepsyFP72013ParticipantEUR 599,740
OPERRAOpen Project for the European Radiation Research AreaFP72013ParticipantEUR 88,440
PANCARELIFEPanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young AdulthoodFP72013ParticipantNot stated
GAPPGAbapentin in Paediatric PainFP72013ParticipantEUR 173,921
NANOATHERONanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibilityFP72013ParticipantEUR 1,049,444
EECEURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing SarcomaFP72013ParticipantEUR 13,661
EMIFEuropean Medical Information FrameworkFP72013ParticipantEUR 191,192
DESIREDevelopment and Epilepsy - Strategies for Innovative Research to improve diagnosis, prevention and treatment in children with difficult to treat EpilepsyFP72013ParticipantEUR 1,281,152
EUROHYP-1European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic strokeFP72012CoordinatorEUR 1,746,226
Pren-IBDInfluence of protein prenylation and its modulation on the immune systemFP72012CoordinatorEUR 167,390
OSTEOIMMUNEOSTEOIMMUNE - Unraveling the Interactions between the Immune System and BoneFP72012ParticipantEUR 233,640
EURO-TEAMTowards Early diagnosis and biomarker validation in Arthritis ManagementFP72012ParticipantEUR 158,000
DEEPDEferiprone Evaluation in PaediatricsFP72011ParticipantEUR 261,513
eHealthMonitorIntelligent Knowledge Platform for Personal Health Monitoring ServicesFP72011ParticipantEUR 234,956
BTCUREBeTheCuREFP72011ParticipantEUR 864,761
SYSKIDSystems biology towards novel chronic kidney disease diagnosis and treatmentFP72010ParticipantEUR 336,160
ADIPOAADIPOSE DERIVED STROMAL CELLS FOR OSTEOARTHRITISFP72010ParticipantEUR 889,944

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.